Resource Guide 5 Hot Topics in Telebehavioral Health & SUD Treatment

Ryan Haight Act 2025. Eric Weintraub MD University of Maryland, School of Medicine ppt download On January 17, 2025, the US Drug Enforcement Administration (DEA) and the US Department of Health and Human Services (HHS) published two rules regarding telemedicine prescribing of controlled substances: a proposed rule implementing the DEA special registration as an exception to the Ryan Haight Act's in-person medical evaluation requirement (Special Registration Proposed Rule) and a final. In 2023, in response to a set of proposed telemedicine rules, DEA received more than 38,000 comments and held two days of public listening sessions

The Controlled Substances Act, as amended by the Ryan Haight Act, generally prohibits prescribing controlled substances via telehealth without a prior in-person examination, subject to certain very limited exceptions. The Ryan Haight Online Pharmacy Consumer Protection Act of 2008 ("Ryan Haight Act") amended the federal Controlled Substances Act ("CSA") to generally mandate that dispensing controlled substances via the Internet requires a valid prescription, which includes at least one (1) in-person medical evaluation.

Flowchart to verify compliance with Ryan Haight Act requirements for

One commenter stated that the Ryan Haight Act does not require an in-person medical evaluation, and if an in-person medical evaluation is required under the Ryan Haight Act, the in-person medical evaluation can be conducted by the prescribing practitioner or a practice group The Controlled Substances Act, as amended by the Ryan Haight Act, generally prohibits prescribing controlled substances via telehealth without a prior in-person examination, subject to certain very limited exceptions. The final rule is effective as of February 18, 2025

Telehealth Opioids and Ryan Haight Act Update. This recently issued extension now extends the flexibilities through December 31, 2025 and marks the third extension of the DEA's temporary rule One commenter stated that the Ryan Haight Act does not require an in-person medical evaluation, and if an in-person medical evaluation is required under the Ryan Haight Act, the in-person medical evaluation can be conducted by the prescribing practitioner or a practice group

Ryan Haight Architectural Portfolio by Ryan Haight Issuu. This new regulation is an exception to the Ryan Haight Act, which generally requires an in-person medical evaluation prior to prescription of a controlled substance In 2023, in response to a set of proposed telemedicine rules, DEA received more than 38,000 comments and held two days of public listening sessions